Similar articles

• Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.

  Onuma Y, Dudek D, Thuesen L, Webster M, Nieman K, Garcia-Garcia HM, Ormiston JA, Serruys PW. Onuma Y, et al. JACC Cardiovasc Interv. 2013 Oct;6(10):999-1009. doi: 10.1016/j.jcin.2013.05.017. JACC Cardiovasc Interv. 2013. PMID: 24156961 Clinical Trial.
• Challenges in multislice computed tomography based fractional flow reserve to evaluate interventional treatment.

  Xu M, Qi X, Song H, Liu Y, Zhou L. Xu M, et al. Catheter Cardiovasc Interv. 2014 Oct 1;84(4):684-5. doi: 10.1002/ccd.25346. Epub 2013 Dec 23. Catheter Cardiovasc Interv. 2014. PMID: 24323738 No abstract available.
• Complex coronary artery disease: would outcomes from the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) trial have differed with newer-generation drug-eluting stents?

  Farooq V, Serruys PW. Farooq V, et al. JACC Cardiovasc Interv. 2013 Oct;6(10):1023-5. doi: 10.1016/j.jcin.2013.07.004. JACC Cardiovasc Interv. 2013. PMID: 24156963 No abstract available.
• Is "the bigger the better" still valid for drug-eluting stents?

  Panoulas VF, Colombo A. Panoulas VF, et al. Catheter Cardiovasc Interv. 2014 May 1;83(6):879-80. doi: 10.1002/ccd.25478. Catheter Cardiovasc Interv. 2014. PMID: 24753167 No abstract available.
• Coronary artery aneurysms after sirolimus-eluting stent implantation: multimodality imaging evaluation.

  Fujino Y, Attizzani GF, Nakamura S, Costa MA, Bezerra HG. Fujino Y, et al. JACC Cardiovasc Interv. 2013 Apr;6(4):423-4. doi: 10.1016/j.jcin.2012.08.023. JACC Cardiovasc Interv. 2013. PMID: 23597611 No abstract available.